Alcoholic liver disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== |
Latest revision as of 20:42, 9 February 2018
Alcoholic liver disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Alcoholic liver disease cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Alcoholic liver disease cost-effectiveness of therapy |
FDA on Alcoholic liver disease cost-effectiveness of therapy |
CDC on Alcoholic liver disease cost-effectiveness of therapy |
Alcoholic liver disease cost-effectiveness of therapy in the news |
Blogs on Alcoholic liver disease cost-effectiveness of therapy |
Risk calculators and risk factors for Alcoholic liver disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: